Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 39, Issue 42, Pages 6556-6571
Publisher
Springer Science and Business Media LLC
Online
2020-09-11
DOI
10.1038/s41388-020-01456-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular Senescence
- (2019) Payel Sen et al. MOLECULAR CELL
- Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers
- (2019) Suzan Stelloo et al. ENDOCRINE-RELATED CANCER
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
- (2019) Yi He et al. Frontiers in Pharmacology
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma
- (2018) Jian-Jun Xie et al. GASTROENTEROLOGY
- A brave new world of RNA-binding proteins
- (2018) Matthias W. Hentze et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Coactivator condensation at super-enhancers links phase separation and gene control
- (2018) Benjamin R. Sabari et al. SCIENCE
- Mediator and RNA polymerase II clusters associate in transcription-dependent condensates
- (2018) Won-Ki Cho et al. SCIENCE
- Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers
- (2018) Aziz Khan et al. Epigenetics
- Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
- (2018) Francesca Zanconato et al. NATURE MEDICINE
- Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
- (2018) Adam Sharp et al. JOURNAL OF CLINICAL INVESTIGATION
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial
- (2017) Axel Heidenreich et al. EUROPEAN UROLOGY
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Gene activation by metazoan enhancers: Diverse mechanisms stimulate distinct steps of transcription
- (2016) Robert A. Beagrie et al. BIOESSAYS
- Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism
- (2016) Min Jia et al. CANCER RESEARCH
- Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
- (2016) Neal D Shore et al. LANCET ONCOLOGY
- Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer
- (2016) Yu Zhao et al. Cell Reports
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs
- (2015) Nasun Hah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
- (2015) Manish Kohli et al. PLoS One
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms of retroviral integration site selection
- (2014) Mamuka Kvaratskhelia et al. NUCLEIC ACIDS RESEARCH
- Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes
- (2014) Ross C. Larue et al. NUCLEIC ACIDS RESEARCH
- Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes
- (2014) Raffaella Di Micco et al. Cell Reports
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Transcriptional Regulation and Its Misregulation in Disease
- (2013) Tong Ihn Lee et al. CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic Loci
- (2013) Kambiz Mousavi et al. MOLECULAR CELL
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Widespread transcription at neuronal activity-regulated enhancers
- (2010) Tae-Kyung Kim et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
- (2010) Y Niu et al. ONCOGENE
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters
- (2008) Leighton J. Core et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started